Researcher.Life Logo

Bioorganic and Medicinal Chemistry Letters : Impact Factor & More

eISSN: 1464-3405pISSN: 0960-894X

Aims and Scope of Bioorganic and Medicinal Chemistry Letters

Bioorganic & Medicinal Chemistry Letters is a scientific journal focusing on the results of research on the molecular structure of biological organisms and the interaction of biological targets with chemical agents. It is published by Elsevier, which also publishes Bioorganic & Medicinal Chemistry for longer works. Less

Key Metrics

CiteScore
5
Impact Factor
< 5
SJR
Q3Biochemistry
SNIP
0.75
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Bioorganic and Medicinal Chemistry Letters

Bioorganic and Medicinal Chemistry Letters Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher PERGAMON-ELSEVIER SCIENCE LTD
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year1991
Publisher URLVisit website
View less

Planning to publish in Bioorganic and Medicinal Chemistry Letters ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Bioorganic and Medicinal Chemistry Letters

Synthesis and biological evaluation of novel pyridone derivatives containing 1,3,4-thiadiazol as potential anticancer agents.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Coumarin-dihydropyrimidinone hybrids as promising agents against ovarian cancer: synthesis, SAR, and in silico evaluation.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Investigating substituted phenylacetamide ligands in the D4R extended binding pocket.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Synthesis of symmetrical bis(indolyl)methanes via Sc(OTf)3 catalyzed tandem C-O and C-C bond breaking reaction and their anti-bacterial studies.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
New benzyldiazepane derivatives able to reduce biofilm formation in Escherichia coli.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Novel 2-aminopyrimidine carboxamide derivatives as potential anti-Alzheimer's disease agents: Design, synthesis, biological activity and computational simulation evaluation.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Synthesis and biological evaluation of novel pyridone derivatives containing 1,3,4-thiadiazol as potential anticancer agents.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Coumarin-dihydropyrimidinone hybrids as promising agents against ovarian cancer: synthesis, SAR, and in silico evaluation.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Investigating substituted phenylacetamide ligands in the D4R extended binding pocket.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Synthesis of symmetrical bis(indolyl)methanes via Sc(OTf)3 catalyzed tandem C-O and C-C bond breaking reaction and their anti-bacterial studies.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
New benzyldiazepane derivatives able to reduce biofilm formation in Escherichia coli.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Novel 2-aminopyrimidine carboxamide derivatives as potential anti-Alzheimer's disease agents: Design, synthesis, biological activity and computational simulation evaluation.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters

FAQs on Bioorganic and Medicinal Chemistry Letters